We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$22.5M
Cap. Flow %
0.53%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
4.4 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.6 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.6 quarters

Top Buys

Rank Stock Value
1
ITCI icon
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS icon
Discover Financial Services
DFS
+$224M
3
BECN icon
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA icon
Walgreens Boots Alliance
WBA
+$110M
5
JWN icon
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR icon
Smartsheet Inc.
SMAR
+$216M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR icon
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XLI icon
226
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
$361K 0.01%
+113,500
New +$15.3M
2025 Q1
0 quarters
SPY icon
227
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$346K 0.01%
85,000
-45,000
-35% -$26.4M
2024 Q2
3 quarters
XBI icon
228
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$329K 0.01%
200,000
+150,000
+300% +$13.4M
2024 Q3
2 quarters
GRAB icon
229
Grab
GRAB
$13.1B
$318K 0.01%
+70,291
New +$328K
2025 Q1
0 quarters
SWTX icon
230
PUT
DELISTED
SpringWorks Therapeutics
SWTX
$315K 0.01%
+45,000
New +$2.07M
2025 Q1
0 quarters
SABR icon
231
PUT
Sabre
SABR
$767M
$303K 0.01%
688,600
– –
2024 Q2
3 quarters
LVS icon
232
PUT
Las Vegas Sands
LVS
$23.4B
$287K 0.01%
37,200
– –
2024 Q1
4 quarters
TRML icon
233
DELISTED
Tourmaline Bio
TRML
$272K 0.01%
+17,860
New +$286K
2025 Q1
0 quarters
NCLH icon
234
PUT
Norwegian Cruise Line
NCLH
$7.15B
$267K 0.01%
188,800
-45,000
-19% -$1.08M
2021 Q2
15 quarters
ORIC icon
235
Oric Pharmaceuticals
ORIC
$1.24B
$266K 0.01%
47,642
-127,204
-73% -$1.11M
2022 Q2
11 quarters
LION icon
236
Lionsgate Studios
LION
$3.31B
$261K 0.01%
35,000
-95,774
-73% -$748K
2024 Q2
3 quarters
CGEM icon
237
Cullinan Oncology
CGEM
$999M
$249K 0.01%
32,903
-23,192
-41% -$223K
2023 Q2
7 quarters
DYN icon
238
Dyne Therapeutics
DYN
$3.11B
$224K 0.01%
21,422
+8,838
+70% +$126K
2022 Q1
12 quarters
DRUG icon
239
Bright Minds Biosciences
DRUG
$533M
$215K 0.01%
+5,963
New +$218K
2025 Q1
0 quarters
EH icon
240
EHang Holdings
EH
$318M
$209K ﹤0.01%
+10,000
New +$203K
2025 Q1
0 quarters
ARQT icon
241
Arcutis Biotherapeutics
ARQT
$3.34B
$206K ﹤0.01%
13,201
-64,354
-83% -$907K
2024 Q3
2 quarters
CATX icon
242
Perspective Therapeutics
CATX
$304M
$205K ﹤0.01%
96,060
-27,183
-22% -$81.6K
2024 Q2
3 quarters
ABBV icon
243
AbbVie
ABBV
$489B
$204K ﹤0.01%
973
-6,515
-87% -$1.27M
2022 Q3
10 quarters
SLN icon
244
Silence Therapeutics
SLN
$613M
$177K ﹤0.01%
62,639
-66,351
-51% -$324K
2022 Q2
11 quarters
IWM icon
245
PUT
iShares Russell 2000 ETF
IWM
$78.5B
$172K ﹤0.01%
45,000
+9,000
+25% +$1.95M
2024 Q4
1 quarter
EWTX icon
246
PUT
Edgewise Therapeutics
EWTX
$4.24B
$169K ﹤0.01%
+45,000
New +$1.18M
2025 Q1
0 quarters
XIFR icon
247
PUT
XPLR Infrastructure LP
XIFR
$978M
$165K ﹤0.01%
20,600
-6,500
-24% -$73.7K
2023 Q3
6 quarters
STWD icon
248
PUT
Starwood Property Trust
STWD
$4.7B
$160K ﹤0.01%
172,500
+34,400
+25% +$676K
2021 Q2
15 quarters
CNTB icon
249
Connect Biopharma Holdings
CNTB
$54.8M
$148K ﹤0.01%
268,946
-241,755
-47% -$224K
2022 Q2
11 quarters
OMF icon
250
PUT
OneMain Financial
OMF
$6.45B
$135K ﹤0.01%
34,400
+3,900
+13% +$207K
2022 Q3
10 quarters
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.